BeStock  
Markets › Compare › JANX vs NVCT

JANX vs NVCT

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
JANX · Janux Therapeutics$10.08 ▼ 2.04%
NVCT · Nuvectis Pharma$19.39 ▼ 2.27%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

5130254379503Nov 24, '25May 26, '26Nov 20, '26
  • JANX -68.0%
  • NVCT +223.7%

Head to head

MetricJANXNVCT
Price$10.08$19.39
Change today▼ 2.04%▼ 2.27%
Market cap$616.73M$666.80M
Return, 3 months-45.8%-18.8%
Return, year to date-27.0%+156.8%
Return, 1 year-65.0%+218.9%
P/E (TTM)––
P/B0.75.3
P/E percentile vs own 5y88th22nd
Dividend yield––
Revenue growth (YoY, latest qtr)-7.1%–
Net profit growth (YoY)+11.3%-303.0%
Gross margin––
Operating margin-599.3%–
Net margin-428.7%–
Return on equity-10.6%-67.0%
Analyst target vs. price+205.6%+77.9%
Analyst buy share75%100%
RSI (14)2547
30-day volatility111.2%78.4%
Max drawdown, 1 year-71.0%-37.7%
Trend readStrong downtrendLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • NVCT is the largest of the group by market value.
  • NVCT has returned the most over the past year.
  • NVCT has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top